Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 110(18): 7452-7, 2013 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-23569269

RESUMO

Despite major advances in our understanding of many aspects of human papillomavirus (HPV) biology, HPV entry is poorly understood. To identify cellular genes required for HPV entry, we conducted a genome-wide screen for siRNAs that inhibited infection of HeLa cells by HPV16 pseudovirus. Many retrograde transport factors were required for efficient infection, including multiple subunits of the retromer, which initiates retrograde transport from the endosome to the trans-Golgi network (TGN). The retromer has not been previously implicated in virus entry. Furthermore, HPV16 capsid proteins arrive in the TGN/Golgi in a retromer-dependent fashion during entry, and incoming HPV proteins form a stable complex with retromer subunits. We propose that HPV16 directly engages the retromer at the early or late endosome and traffics to the TGN/Golgi via the retrograde pathway during cell entry. These results provide important insights into HPV entry, identify numerous potential antiviral targets, and suggest that the role of the retromer in infection by other viruses should be assessed.


Assuntos
Genoma Humano/genética , Papillomaviridae/fisiologia , Interferência de RNA , RNA Interferente Pequeno/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Internalização do Vírus , Complexo de Golgi/virologia , Células HeLa , Papillomavirus Humano 16/fisiologia , Humanos , Infecções por Papillomavirus/genética , Infecções por Papillomavirus/virologia , Ligação Proteica , Transporte Proteico , Reprodutibilidade dos Testes , Proteínas Virais/metabolismo
2.
Toxicol Appl Pharmacol ; 232(1): 78-85, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18640140

RESUMO

Epidemiological evidence indicates that prolonged lifetime exposure to estrogen is associated with elevated breast cancer risk in women. Oxidative stress and estrogen receptor-associated proliferative changes are suggested to play important roles in estrogen-induced breast carcinogenesis. In the present study, we investigated changes in breast morphology and oxidative stress following estrogen exposure. Female ACI rats were treated with 17beta-estradiol (E(2), 3 mg, s.c.) for either 7, 15, 120 or 240 days. Animals were euthanized, tissues were excised, and portions of the tissues were either fixed in 10% buffered formalin or snap-frozen in liquid nitrogen. Paraffin-embedded tissues were examined for histopathologic changes. Proliferative changes appeared in the breast after 7 days of E(2) exposure. Atypical ductal proliferation and significant reduction in stromal fat were observed following 120 days of E(2) exposure. Both in situ and invasive carcinomas were observed in the majority of the mammary glands from rats treated with E(2) for 240 days. Palpable breast tumors were observed in 82% of E(2)-treated rats after 228 days, with the first palpable tumor appearing after 128 days. No morphological changes were observed in the livers, kidneys, lungs or brains of rats treated with E(2) for 240 days compared to controls. Furthermore, 8-isoprostane (8-isoPGF(2alpha)) levels as well as the activities of antioxidant enzymes, such as glutathione peroxidase, superoxide dismutase and catalase, were quantified in the breast tissues of rats treated with E(2) for 7, 15, 120 and 240 days and compared to activity levels in age-matched controls. 8-isoPGF(2alpha) levels displayed time-dependent increases upon E(2) treatment and were significantly higher than control levels at the 15, 120 and 240 day time-points. 8-isoPGF(2alpha) observed in E(2)-induced mammary tumors were significantly higher than levels found in control mammary tissue from age-matched animals. Similarly, alterations in glutathione peroxidase and superoxide dismutase activities were detected in both mammary and tumor tissue from E(2)-treated rats. Taken together, our data reveal that proliferative changes in the breast tissue of ACI rats are associated with increases in 8-isoPGF(2alpha) formation as well as changes in the activities of antioxidant enzymes. These oxidative changes appear to be a function of E(2) exposure and occur prior to tumor development.


Assuntos
Proliferação de Células , Glândulas Mamárias Animais , Neoplasias Mamárias Experimentais/induzido quimicamente , Neoplasias Hormônio-Dependentes/induzido quimicamente , Estresse Oxidativo , Animais , Catalase/metabolismo , Dinoprosta/análogos & derivados , Dinoprosta/metabolismo , Modelos Animais de Doenças , Implantes de Medicamento , Estradiol/administração & dosagem , Feminino , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos , Glândulas Mamárias Animais/enzimologia , Glândulas Mamárias Animais/patologia , Neoplasias Mamárias Experimentais/metabolismo , Neoplasias Mamárias Experimentais/patologia , Invasividade Neoplásica , Neoplasias Hormônio-Dependentes/metabolismo , Neoplasias Hormônio-Dependentes/patologia , Ratos , Ratos Endogâmicos ACI , Superóxido Dismutase/metabolismo , Fatores de Tempo , Regulação para Cima
3.
J Ethnopharmacol ; 109(3): 406-11, 2007 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-17088035

RESUMO

Pippaliyadi yoga or pippaliyadi vati is an ayurvedic contraceptive used in India since ancient times. It is a combination of powdered fruit berries of Embelia ribes Burm.f. (Myrsinaceae), Piper longum L. (Piperaceae) and borax in equal proportion. Though the contraceptive potential is known since ancient times, no systematic developmental toxicity studies have been carried out. The present study was carried out to evaluate the postnatal developmental toxicity and the reproductive performance of the progeny exposed in utero to pippaliyadi. Pippaliyadi yoga was obtained from National Institute for Pharmaceutical Education and Research (NIPER), India and the developmental toxicity was studied by administering three doses, viz. 140, 300 and 700 mg/(kg day) to gravid females from day 6 to day 16 of gestation. Pippaliyadi did not have any adverse developmental effects with low doses, however, with the five times higher dose, a decrease in body weight of the pups was observed. The reproductive performance of the progeny born to mothers treated with pippaliyadi was not significantly affected. The present study suggests that in utero exposure to pippaliyadi does not have any adverse effect on the postnatal development and reproductive performance of the F(1) progeny.


Assuntos
Anticoncepcionais Femininos/farmacologia , Embelia , Piper , Preparações de Plantas/farmacologia , Animais , Feminino , Frutas/química , Cabelo/efeitos dos fármacos , Cabelo/crescimento & desenvolvimento , Masculino , Troca Materno-Fetal , Ayurveda , Gravidez , Ratos , Ratos Sprague-Dawley , Reprodução/efeitos dos fármacos , Vagina/efeitos dos fármacos , Vagina/crescimento & desenvolvimento
4.
Rev Environ Health ; 20(1): 39-56, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15835497

RESUMO

Mercury is a heavy metal that is found naturally in the environment in various forms. Human activity can release mercury into the air, water, and soil. Mercury is also released into the environment after its conversion to methylmercury by bacteria. Mercury was once used in medicine, but the medicinal aspect changed because of its devastating poisoning effect on humans and animals. Today, mercury is one of the most potent neurotoxins known, having a number of adverse health effects in animals and humans. As the sources of mercury are many, the general population is exposed to mercury in day-to-day life, in occupational settings, and in cases of accidental exposure. In addition, ignorance about the use of mercury in cosmetics and religious materials has opened an additional source of exposure. Therefore, making people aware of mercury's effects on health, its sources of entry into the environment, and its chelating remedies becomes a necessity so that strategies can be adopted to minimize use and exposure.


Assuntos
Exposição Ambiental , Poluentes Ambientais/toxicidade , Intoxicação por Mercúrio/complicações , Mercúrio/toxicidade , Exposição Ocupacional , Reprodução/efeitos dos fármacos , Biotransformação , Quelantes , Feminino , Humanos , Masculino , Intoxicação por Mercúrio/terapia , Compostos de Metilmercúrio/toxicidade , Saúde Pública
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa